TET2 and chronic myelomonocytic leukemia: Inactivation of TET2 induces a decrease in the levels of 5 hmC in myeloid progenitors and a dysregulation of hematopoietic stem cells leading to the development of myeloid malignancies similar to CMML [9], [10], [11].